The Journal of Cell Biology, Vol 122, 1067-1077, Copyright © 1993 by The Rockefeller University Press

ARTICLES

Activated mouse astrocytes and T cells express similar CD44 variants. Role of CD44 in astrocyte/T cell binding

H Haegel, C Tolg, M Hofmann and R Ceredig
Laboratoire de Genetique Moleculaire des Eucaryotes/CNRS, U184/INSERM, Institut de Chimie Biologique, Faculte de Medecine, Strasbourg, France.

The CD44 adhesion molecule is expressed by astrocytes, glial-type cells which exhibit features of accessory cells for immune responses in the central nervous system. In primary cultures of mouse astrocytes, we have observed that surface expression and mRNA levels of CD44 are induced following stimulation with either PMA, or tumor necrosis factor alpha plus gamma interferon. Comparison of CD44 splice variants expressed by astrocytes and a T cell hybridoma shows that upon activation, both cell types express a similar pattern of CD44 transcripts. Thus, in both cell types, CD44 transcripts are produced which contain additional exons, including the exon v6 (known to be expressed by in vivo activated lymphocytes and by metastatic variants of tumor cells) as well as variants of larger size. In the autoimmune disease multiple sclerosis, activated T cells cross the blood-brain barrier and lead to inflammation in the central nervous system. Analysis of mice with experimental allergic encephalomyelitis, frequently used as an animal model of multiple sclerosis, shows that CD44 is induced in vivo on glial cells surrounding inflammatory lesions. Using an in vitro model for adhesion between T cells and astrocytes, we have found a correlation between the activation state of these cells and their adhesion potential. Dose-dependent inhibition of adhesion by hyaluronate and by anti-CD44 monoclonal antibody KM81 shows that CD44 is involved in the adhesive interactions between T cells and astrocytes.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Levesque, M. C., Haynes, B. F. (2001). Activated T Lymphocytes Regulate Hyaluronan Binding to Monocyte CD44 Via Production of IL-2 and IFN-{{gamma}}. J. Immunol. 166: 188-196 [Abstract] [Full Text]  
• Singhrao, S. K., Neal, J. W., Rushmere, N. K., Morgan, B. P., Gasque, P. (2000). Spontaneous Classical Pathway Activation and Deficiency of Membrane Regulators Render Human Neurons Susceptible to Complement Lysis. Am. J. Pathol. 157: 905-918 [Abstract] [Full Text]  
• Brocke, S., Piercy, C., Steinman, L., Weissman, I. L., Veromaa, T. (1999). Antibodies to CD44 and integrin alpha 4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc. Natl. Acad. Sci. USA 96: 6896-6901 [Abstract] [Full Text]  
• Haegel-Kronenberger, H., de la Salle, H., Bohbot, A., Oberling, F., Cazenave, J.-P., Hanau, D. (1998). Adhesive and/or Signaling Functions of CD44 Isoforms in Human Dendritic Cells. J. Immunol. 161: 3902-3911 [Abstract] [Full Text]  
• Roca, X., Mate, J. L., Ariza, A., Munoz-Marmol, A. M., von Uexkull-Guldeband, C., Pellicer, I., Navas-Palacios, J. J., Isamat, M. (1998). CD44 Isoform Expression Follows Two Alternative Splicing Pathways in Breast Tissue. Am. J. Pathol. 153: 183-190 [Abstract] [Full Text]  
• Laman, J D, Maassen, C B., Schellekens, M M, Visser, L, Kap, M, de Jong, E, van Puijenbroek, M, van Stipdonk, M J., van Meurs, M, Schwarzler, C, Gunthert, U (1998). Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide. Mult Scler 4: 147-153 [Abstract]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents